<DOC>
	<DOCNO>NCT02470390</DOCNO>
	<brief_summary>A partially randomize , open-label , 3-way crossover , single-center , systemic CSF PK bioavailability study healthy volunteer .</brief_summary>
	<brief_title>Opel Label Cross Over Study Pharmacokinetics ( PK ) Study Healthy Volunteers Recieving Various Forms Fentanyl</brief_title>
	<detailed_description>An Open-Label Single-Dose Crossover Study Comparing Plasma Cerebrospinal Fluid Pharmacokinetics Bioavailability Fentanyl Delivered Intranasally Versus Sublingually Versus Intravenously Healthy Volunteers</detailed_description>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Normal healthy male female age 18 65 year . Never smokers Nonsmokers ( cessation smoke ≥ 6 month ago ) . Body Mass Index ( BMI = weight/height2 ) great equal 18.5 kg/m2 less equal 32.0 kg/m2 . No clinically meaningful finding physical examination , oral nasal examination 12lead electrocardiogram . Negative drug abuse , alcohol , nicotine . Negative hepatitis A , B , C Human Immunodeficiency Virus ( HIV ) . No clinical laboratory value outside acceptable range , unless , opinion Principal Investigator , deem clinically significant . Subject known history allergic reaction , hypersensitivity , clinically significant intolerance opioids , fentanyl component study drug . 2 . Subjects high potential opioid addiction ( personal family history ) . 3 . Subject lactating consider risk pregnancy . 4 . Subject impaired liver function ( e.g. , alanine aminotransferase [ ALT ] ≥ 3 time upper limit normal [ ULN ] bilirubin ≥ 3 time ULN ) , know active hepatic disease ( e.g. , hepatitis ) , evidence clinically significant liver disease condition affect liver may suggest potential increased susceptibility hepatic toxicity oral diclofenac exposure . 5 . Subject history renal disease , opinion investigator , would contraindicate study participation ; subject significantly impaired renal function evidence estimate GFR ≤60 ml/min/1.73m2 . 6 . Subject history evidence significant nasal pathology , include polyp nasal obstruction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Volunteer</keyword>
	<keyword>Pharmacokenetics ( PK ) ( plasma Cerebrospinal Fluid [ CSF ] )</keyword>
</DOC>